Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProSomnus, Inc. - Common Stock (NQ: OSA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.4107 (50)
Ask (Size) 0.4850 (40)
Prev. Close 0.4700
Today's Range N/A - N/A
52wk Range 0.4616 - 1.360
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023
OSA stock results show that ProSomnus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

More News

Read More
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Roth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For March 26, 2024
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Sleep Devices Focused ProSomnus Stock Soaring Today?
Via Benzinga
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
ProSomnus Announces Third Quarter 2023 Investor Call and Business Update
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
From ProSomnus Sleep Technologies, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.